(UL) Unilever - Ratings and Ratios
BeautyProducts, PersonalCare, HomeCare, Foods, IceCream
Description: UL Unilever
Unilever PLC is a diversified fast-moving consumer goods company with a presence in multiple regions, operating through five key segments: Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream. The companys product portfolio includes a wide range of well-known brands such as AXE, Ben & Jerrys, Dove, Hellmanns, and Magnum, among others.
From a strategic perspective, Unilevers diversified portfolio and global reach provide a stable foundation for growth. Key Performance Indicators (KPIs) to monitor include revenue growth, gross margin expansion, and operating margin improvement. Additionally, metrics such as brand strength, market share, and product innovation pipeline are crucial in assessing the companys competitive position and long-term prospects.
Unilevers financial health can be evaluated using metrics such as Return on Equity (RoE) of 53.09%, indicating a strong ability to generate profits from shareholder equity. The companys dividend yield and payout ratio are also important metrics to consider, as they reflect the companys ability to return value to shareholders. Furthermore, the Price-to-Earnings (P/E) ratio of 22.81 and Forward P/E of 16.56 suggest that the stock may be reasonably valued relative to its earnings growth prospects.
To further analyze Unilevers prospects, its essential to examine its segment-wise performance, geographic revenue distribution, and product category trends. For instance, the companys Beauty & Wellbeing and Personal Care segments are likely to be influenced by trends in the global beauty and personal care market, while the Foods and Ice Cream segments are subject to changing consumer preferences and dietary habits.
UL Stock Overview
| Market Cap in USD | 149,758m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 1988-01-04 |
UL Stock Ratings
| Growth Rating | 17.4% |
| Fundamental | 80.3% |
| Dividend Rating | 41.5% |
| Return 12m vs S&P 500 | -13.5% |
| Analyst Rating | 4.0 of 5 |
UL Dividends
| Dividend Yield 12m | 3.26% |
| Yield on Cost 5y | 3.94% |
| Annual Growth 5y | 0.18% |
| Payout Consistency | 96.2% |
| Payout Ratio | 88.4% |
UL Growth Ratios
| Growth Correlation 3m | -28.8% |
| Growth Correlation 12m | 15.8% |
| Growth Correlation 5y | 43.4% |
| CAGR 5y | 4.63% |
| CAGR/Max DD 5y | 0.17 |
| Sharpe Ratio 12m | -0.44 |
| Alpha | -3.67 |
| Beta | 0.082 |
| Volatility | 17.59% |
| Current Volume | 1532.5k |
| Average Volume 20d | 2036.4k |
| Stop Loss | 60.6 (-3.1%) |
| Signal | 1.53 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (12.20b TTM) > 0 and > 6% of Revenue (6% = 7.20b TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 3.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.92% (prev -6.18%; Δ 1.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.24 (>3.0%) and CFO 17.87b > Net Income 12.20b (YES >=105%, WARN >=100%) |
| Net Debt (24.52b) to EBITDA (18.04b) ratio: 1.36 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.45b) change vs 12m ago -3.02% (target <= -2.0% for YES) |
| Gross Margin 71.32% (prev 23.98%; Δ 47.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 158.7% (prev 120.5%; Δ 38.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 30.93 (EBITDA TTM 18.04b / Interest Expense TTM 518.7m) >= 6 (WARN >= 3) |
Altman Z'' -1.22
| (A) -0.08 = (Total Current Assets 19.19b - Total Current Liabilities 25.10b) / Total Assets 76.00b |
| (B) -0.46 = Retained Earnings (Balance) -35.14b / Total Assets 76.00b |
| (C) 0.21 = EBIT TTM 16.04b / Avg Total Assets 75.63b |
| (D) -0.60 = Book Value of Equity -35.05b / Total Liabilities 58.20b |
| Total Rating: -1.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.29
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 8.47% = 4.23 |
| 3. FCF Margin 10.73% = 2.68 |
| 4. Debt/Equity 1.40 = 1.60 |
| 5. Debt/Ebitda 1.38 = 1.17 |
| 6. ROIC - WACC 24.58% = 12.50 |
| 7. RoE 64.03% = 2.50 |
| 8. Rev. Trend 22.92% = 1.15 |
| 9. Rev. CAGR 4.56% = 0.57 |
| 10. EPS Trend -32.82% = -0.82 |
| 11. EPS CAGR 17.12% = 1.71 |
What is the price of UL shares?
Over the past week, the price has changed by -1.64%, over one month by +6.48%, over three months by -1.08% and over the past year by +0.83%.
Is Unilever a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UL is around 59.80 USD . This means that UL is currently overvalued and has a potential downside of -4.35%.
Is UL a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the UL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70.8 | 13.2% |
| Analysts Target Price | 65.9 | 5.4% |
| ValueRay Target Price | 64.9 | 3.8% |
Last update: 2025-08-14 02:55
UL Fundamental Data Overview
CCE Cash And Equivalents = 1.23b EUR (last quarter)
P/E Trailing = 23.4023
P/E Forward = 16.4745
P/S = 2.5055
P/B = 7.2038
P/EG = 1.8096
Beta = 0.205
Revenue TTM = 120.06b EUR
EBIT TTM = 16.04b EUR
EBITDA TTM = 18.04b EUR
Long Term Debt = 24.87b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 24.87b EUR (Calculated: Short Term 0.0 + Long Term 24.87b)
Net Debt = 24.52b EUR (from netDebt column, last fiscal year)
Enterprise Value = 152.19b EUR (128.55b + Debt 24.87b - CCE 1.23b)
Interest Coverage Ratio = 30.93 (Ebit TTM 16.04b / Interest Expense TTM 518.7m)
FCF Yield = 8.47% (FCF TTM 12.89b / Enterprise Value 152.19b)
FCF Margin = 10.73% (FCF TTM 12.89b / Revenue TTM 120.06b)
Net Margin = 10.16% (Net Income TTM 12.20b / Revenue TTM 120.06b)
Gross Margin = 71.32% ((Revenue TTM 120.06b - Cost of Revenue TTM 34.43b) / Revenue TTM)
Tobins Q-Ratio = -4.34 (set to none) (Enterprise Value 152.19b / Book Value Of Equity -35.05b)
Interest Expense / Debt = 2.09% (Interest Expense 518.7m / Debt 24.87b)
Taxrate = 28.19% (from yearly Income Tax Expense: 2.50b / 8.87b)
NOPAT = 11.52b (EBIT 16.04b * (1 - 28.19%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.40 (Debt 24.87b / last Quarter total Stockholder Equity 17.79b)
Debt / EBITDA = 1.38 (Net Debt 24.52b / EBITDA 18.04b)
Debt / FCF = 1.93 (Debt 24.87b / FCF TTM 12.89b)
Total Stockholder Equity = 19.05b (last 4 quarters mean)
RoA = 16.05% (Net Income 12.20b, Total Assets 76.00b )
RoE = 64.03% (Net Income TTM 12.20b / Total Stockholder Equity 19.05b)
RoCE = 36.53% (Ebit 16.04b / (Equity 19.05b + L.T.Debt 24.87b))
RoIC = 30.12% (NOPAT 11.52b / Invested Capital 38.26b)
WACC = 5.54% (E(128.55b)/V(153.42b) * Re(6.32%)) + (D(24.87b)/V(153.42b) * Rd(2.09%) * (1-Tc(0.28)))
Shares Correlation 5-Years: -90.0 | Cagr: -1.08%
Discount Rate = 6.32% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈11.82b ; Y1≈14.58b ; Y5≈24.88b
Fair Price DCF = 172.6 (DCF Value 423.15b / Shares Outstanding 2.45b; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 22.92 | Revenue CAGR: 4.56%
Rev Growth-of-Growth: 32.99
EPS Correlation: -32.82 | EPS CAGR: 17.12%
EPS Growth-of-Growth: 21.15
Additional Sources for UL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle